Memo to Owners of Original Content

I have been to your website and read your Terms of Use. I understand you have granted me you a limited, personal, revocable, non-exclusive, and non-transferable license to use your Services for my personal, non-commercial use only and can print or download pieces of the Content for my personal and non-commercial use.

Now that we have gotten that out of the way…

“Last fall, there were reports that antibodies wane quickly after infection with SARS-CoV-2, and mainstream media interpreted that to mean that immunity was not long-lived,” said senior author Ali Ellebedy, PhD, Washington University School of Medicine, St. Louis, Missouri. “But that’s a misinterpretation of the data. It’s normal for antibody levels to go down after acute infection, but they don’t go down to zero — they plateau. Here, we found antibody-producing cells in people 11 months after first symptoms. These cells will live and produce antibodies for the rest of people’s lives. That’s strong evidence for long-lasting immunity.”

Mild COVID-19 Induces Lasting Antibody Protection — https://ntk-institute.org/article/mild-covid-19-induces-lasting-antibody-protection

Here’s the link to the original research article abstract:

Turner, J.S., Kim, W., Kalaidina, E. et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature (2021). https://doi.org/10.1038/s41586-021-03647-4